97 related articles for article (PubMed ID: 9880906)
1. Synthesis of an N-glucoasparagine analog as a building block for a V3-loop glycopeptide from gp120 of HIV-I.
Schäfer A; Klich G; Schreiber M; Paulsen H; Thiem J
Carbohydr Res; 1998 Dec; 313(2):107-16. PubMed ID: 9880906
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and conformational studies of N-glycosylated analogues of the HIV-1 principal neutralizing determinant.
Laczkó I; Hollósi M; Urge L; Ugen KE; Weiner DB; Mantsch HH; Thurin J; Otvös L
Biochemistry; 1992 May; 31(17):4282-8. PubMed ID: 1567873
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of N4-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine analogues: succinamide, L-2-hydroxysuccinamide, and L-2-hydroxysuccinamic acid hydrazide analogues.
De Huang H; Risley JM
Carbohydr Res; 2000 Nov; 329(3):487-93. PubMed ID: 11128578
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the V3 loop of a Thailand HIV isolate.
Gupta G; Anantharamaiah GM; Scott DR; Eldridge JH; Myers G
J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.
Huang X; Barchi JJ; Lung FD; Roller PP; Nara PL; Muschik J; Garrity RR
Biochemistry; 1997 Sep; 36(36):10846-56. PubMed ID: 9312273
[TBL] [Abstract][Full Text] [Related]
6. Chemoenzymatic synthesis of HIV-1 V3 glycopeptides carrying two N-glycans and effects of glycosylation on the peptide domain.
Li H; Li B; Song H; Breydo L; Baskakov IV; Wang LX
J Org Chem; 2005 Nov; 70(24):9990-6. PubMed ID: 16292832
[TBL] [Abstract][Full Text] [Related]
7. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
McCaffrey RA; Saunders C; Hensel M; Stamatatos L
J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
[TBL] [Abstract][Full Text] [Related]
8. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
[TBL] [Abstract][Full Text] [Related]
9. Highly regioselective synthesis of a 3-O-sulfonated arabino Lewis(a) asparagine building block suitable for glycopeptide synthesis.
Rösch A; Kunz H
Carbohydr Res; 2006 Jul; 341(10):1597-608. PubMed ID: 16584716
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.
Andrianov AM; Veresov VG
J Biomol Struct Dyn; 2007 Jun; 24(6):597-608. PubMed ID: 17508782
[TBL] [Abstract][Full Text] [Related]
11. Local structural properties of the V3 loop of Thailand HIV-1 isolate.
Andrianov AM
J Biomol Struct Dyn; 2002 Jun; 19(6):973-89. PubMed ID: 12023800
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
Neurath AR; Strick N; Debnath AK
J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
[TBL] [Abstract][Full Text] [Related]
13. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
Stanfield RL; Ghiara JB; Ollmann Saphire E; Profy AT; Wilson IA
Virology; 2003 Oct; 315(1):159-73. PubMed ID: 14592768
[TBL] [Abstract][Full Text] [Related]
14. The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions.
Zvi A; Kustanovich I; Hayek Y; Matsushita S; Anglister J
FEBS Lett; 1995 Jul; 368(2):267-70. PubMed ID: 7543061
[TBL] [Abstract][Full Text] [Related]
15. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.
Ivanoff LA; Looney DJ; McDanal C; Morris JF; Wong-Staal F; Langlois AJ; Petteway SR; Matthews TJ
AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461
[TBL] [Abstract][Full Text] [Related]
16. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
17. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.
Ebenbichler C; Westervelt P; Carrillo A; Henkel T; Johnson D; Ratner L
AIDS; 1993 May; 7(5):639-46. PubMed ID: 7686374
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of anti-HIV activity of succinylated human serum albumin.
Kuipers ME; vd Berg M; Swart PJ; Laman JD; Meijer DK; Koppelman MH; Huisman H
Biochem Pharmacol; 1999 Apr; 57(8):889-98. PubMed ID: 10086322
[TBL] [Abstract][Full Text] [Related]
19. [A functional model of the central epitope of the V3 loop of HIV-1 gp120 when complexed with antibodies].
Shchelkanov MIu; Iaroslavtseva NG; Emel'ianov AV; Sakhuriia IB; Abélian AV; Verevochkin SV; Kozlov AP; Karamov EV
Mol Biol (Mosk); 1998; 32(6):1062-74. PubMed ID: 9929887
[No Abstract] [Full Text] [Related]
20. A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.
Zvi A; Tugarinov V; Faiman GA; Horovitz A; Anglister J
Eur J Biochem; 2000 Feb; 267(3):767-79. PubMed ID: 10651813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
